2023-Jan-27: FDA VRBPAC: COVID-19 Vaccine Composition Going Forward
The FDA VRBPAC (Vaccines and Related Biological Products Advisory Committee) met this week to discuss the composition of vaccines going forward. In particular, should we consolidate on a series of bivalent shots instead of the current mixture of old and new?